Prummel M F, Wiersinga W M
Department of Endocrinology, University of Amsterdam, The Netherlands.
JAMA. 1993 Jan 27;269(4):479-82.
To assess if smoking is associated with Graves' disease and, if so, to ascertain whether this association persists when controlling for confounding factors.
Consecutive entry case-control study with two age- and sex-matched control subjects from two different populations per case patient.
University hospital.
Five groups were studied: (1) Graves' ophthalmopathy and Graves' hyperthyroidism (n = 100; divided in four subgroups according to the severity of the eye disease); (2) Graves' hyperthyroidism without clinical eye involvement (n = 100); (3) sporadic nontoxic goiter (n = 100); (4) autoimmune hypothyroidism (n = 75); and (5) toxic nodular goiter (n = 75). The study comprised 200 subjects from a hospital-based population, and 200 from a population-based group served as control subjects.
Smoking status was determined from a questionnaire at the time of onset of the disease to exclude any effect of the disease itself on smoking.
Smoking greatly increased the risk for Graves' ophthalmopathy (odds ratio, 7.7; 95% confidence interval, 4.3 to 13.7), but patients with Graves' hyperthyroidism alone were also more often smokers than control subjects (odds ratio, 1.9; 95% confidence interval, 1.1 to 3.2). Smoking was not associated with the other thyroid diseases studied. Essentially similar results were obtained after adjustment for differences in education between case patients and control subjects. Among the patients with Graves' ophthalmopathy, smokers had more severe eye disease than nonsmokers, but no association was found between the number of cigarettes smoked per day or the duration of smoking and the severity of the ophthalmopathy. However, there was a significant increase in the odds ratios in patients with more severe eye disease.
Smoking is associated with Graves' disease, and it especially increases the risk for the development of more severe ophthalmopathy. Thus, smoking appears to be one of the multiple factors inducing Graves' disease in genetically predisposed individuals.
评估吸烟是否与格雷夫斯病相关,若相关,则确定在控制混杂因素时这种关联是否仍然存在。
连续纳入病例对照研究,每个病例患者有来自两个不同人群的两名年龄和性别匹配的对照对象。
大学医院。
研究了五组:(1)格雷夫斯眼病和格雷夫斯甲亢(n = 100;根据眼病严重程度分为四个亚组);(2)无临床眼部受累的格雷夫斯甲亢(n = 100);(3)散发性非毒性甲状腺肿(n = 100);(4)自身免疫性甲减(n = 75);以及(5)毒性结节性甲状腺肿(n = 75)。该研究包括来自医院人群的200名受试者,以及来自社区人群的200名受试者作为对照对象。
在疾病发作时通过问卷调查确定吸烟状况,以排除疾病本身对吸烟的任何影响。
吸烟显著增加了格雷夫斯眼病的风险(优势比,7.7;95%置信区间,4.3至13.7),但仅患有格雷夫斯甲亢的患者吸烟者也比对照对象更常见(优势比,1.9;95%置信区间,1.1至3.2)。吸烟与所研究的其他甲状腺疾病无关。在对病例患者和对照对象之间的教育差异进行调整后,获得了基本相似的结果。在患有格雷夫斯眼病的患者中,吸烟者的眼病比不吸烟者更严重,但未发现每日吸烟量或吸烟持续时间与眼病严重程度之间存在关联。然而,眼病更严重的患者的优势比有显著增加。
吸烟与格雷夫斯病相关,尤其增加了发生更严重眼病的风险。因此,吸烟似乎是在遗传易感性个体中诱发格雷夫斯病的多种因素之一。